| Authors: |
Baertsch MA; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Schlenzka J; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Hielscher T; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Raab MS; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Sauer S; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Merz M; Department of Hematology, Cell Therapy, Hemostaseology and Infectiology, Leipzig University Hospital, Leipzig, Germany., Mai EK; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Müller-Tidow C; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Luntz S; Coordination Centre for Clinical Trials, University Hospital Heidelberg, Heidelberg, Germany., Jauch A; Institute for Human Genetics, University of Heidelberg, Heidelberg, Germany., Brossart P; Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, Medizinische Klinik und Poliklinik III, University Hospital Bonn, Bonn, Germany., Goerner M; Department of Hematology, Oncology and Palliative Care, Community Hospital Bielefeld, Bielefeld, Germany., Klein S; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany., Glass B; Department of Hematology and Cellular Therapy, Helios Hospital Berlin-Buch, Berlin, Germany., Reimer P; Department of Hematology, Oncology and Stem Cell Transplantation, Evangelische Kliniken Essen-Mitte, Essen, Germany., Graeven U; Department of Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Duesseldorf, Germany., Haenel M; Department of Hematology, Oncology and Stem Cell Transplantation, Klinikum Chemnitz GmbH, Chemnitz, Germany., von Metzler I; Department of Hematology and Oncology, Goethe University, Frankfurt, Germany., Lindemann HW; Department of Hematology and Oncology, Katholisches Krankenhaus Hagen gem. GmbH, Hagen, Germany., Scheid C; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Blau IW; Internal Medicine III, Charité Campus Benjamin Franklin, Berlin, Germany., Salwender HJ; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany., Noppeney R; Department of Hematology, University Hospital Essen, Essen, Germany., Besemer B; Department of Hematology, Hematology, Oncology, Immunology, and Rheumatology, University of Tuebingen, Tuebingen, Germany., Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Goldschmidt H; Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. |
